Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

I guess that could be one explanation but it wasn't my point.

I guess I need to explain. Per an October 2016 PR:
“We look forward to efficient execution of this important trial for our psoriasis program. Having partnered with one of the premier CROs in the Dermatology therapy area for this study, I am confident that we will be able to assess interim and final study results in a timely fashion,” said Jane Harness, Cellceutix VP, Clinical Sciences and Portfolio Management.

No interim Prurisol assessment, timely or otherwise, was made....or at least none was announced as far as I know. The point of my post was to raise the question as to whether an interim assessment, as was done by Protagonist, might have saved IPIX shareholders some money and/or dilutive issuances expended on the Prurisol trial. I guess we'll never know that. Will they re-test the 200 mg trial or will we never know that either? The Company said it was successful in the mild-to-moderate population. It was one of those trials that never failed.